Chemoinformaics analysis of 3-o-methyl-ellagic acid
| Molecular Weight | 448.336 | nRot | 3 |
| Heavy Atom Molecular Weight | 432.208 | nRig | 27 |
| Exact Molecular Weight | 448.064 | nRing | 5 |
| Solubility: LogS | -4.3 | nHRing | 3 |
| Solubility: LogP | -0.158 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 12 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 12 | No. of Arom Bond | 19 |
| nHA | 12 | APOL | 53.6927 |
| nHD | 5 | BPOL | 26.4673 |
| QED | 0.204 |
| Synth | 4.246 |
| Natural Product Likeliness | 1.999 |
| NR-PPAR-gamma | 0.657 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.998 |
| HIA | 0.729 |
| CACO-2 | -6.278 |
| MDCK | 0.0000206 |
| BBB | 0.041 |
| PPB | 0.71068 |
| VDSS | 0.959 |
| FU | 0.297639 |
| CYP1A2-inh | 0.219 |
| CYP1A2-sub | 0.459 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.077 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.153 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.041 |
| CYP3a4-sub | 0.009 |
| CL | 1.139 |
| T12 | 0.714 |
| hERG | 0.011 |
| Ames | 0.311 |
| ROA | 0.045 |
| SkinSen | 0.554 |
| Carcinogencity | 0.05 |
| EI | 0.05 |
| Respiratory | 0.044 |
| NR-Aromatase | 0.729 |
| Antiviral | Yes |
| Prediction | 0.711019 |